AARTIDRUGSNSEAarti Drugs Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 6 Apr · 14:57 IST

Aarti Drugs Limited has informed the Exchange regarding a press release dated April 06, 2026, titled "Second 100 days Campaign".

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹354.45
prior close
₹352.05
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.2+0.9+0.6+0.4+2.3+0.9+0.0-0.5+5.0+7.5+11.7+3.0+7.0
Up moveDown movePending
AI summary

Aarti Drugs Limited is relaunching the IEPFA-initiated Second 100 Days Campaign titled 'Saksham Niveshak' from April 1, 2026 to July 9, 2026. The campaign urges shareholders with unpaid or unclaimed dividends to update their KYC details (PAN, nomination, contact info, bank account, specimen signature) with the RTA, MUFG Intime India Private Limited, or their Depository Participant. The company will send letters/emails to affected shareholders with dividend details. Shareholders must act before July 9, 2026, or dividends unclaimed for seven consecutive years — and the underlying shares — will be transferred to the Investor Education and Protection Fund (IEPF). Details of unclaimed dividends for the past seven years are available on the company website.

Likely market impact

No direct financial impact on the company's stock or financials. This is a compliance-driven shareholder outreach. However, shareholders who fail to claim dividends risk permanent loss of unpaid amounts and potential transfer of their equity shares to IEPF.